Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to evaluate if a drug called nebivolol can reverse inappropriate left ventricular mass (LVM) when compared to the standard of care drug metoprolol.
Epistemonikos ID: 892cf738a4614a9fe59c9ac24af80cd2a729ad0c
First added on: May 11, 2024